Wang Hong Kai
Wang Hong Kai — Associate Chief Physician — Urology — Fudan University Affiliated Cancer Hospital
Specialties
Robot-assisted radical prostatectomy, especially individualized nerve-sparing surgery, surgeries that preserve and improve urinary control function, and pelvic lymph node dissection
Professional Experience
Chief surgeon of the Prostate Cancer Specialty Group, Department of Urology, Fudan University Affiliated Cancer Hospital; Assistant Director of the Department of Urology; Associate Chief Physician. Skilled in robot-assisted radical prostatectomy and proficient in various techniques for preserving erectile and urinary functions, such as VIP technique, HOLD technique, bladder neck preservation technique, and peri-anastomotic reconstruction technique. Performs or participates in over 600 robot-assisted radical prostatectomies annually. As SUBI, responsible for the clinical trial of the 'Haishan One' split modular robot and oversees multiple clinical trials for localized and metastatic prostate cancer. Expert in comprehensive treatment of urological tumors (prostate cancer, kidney cancer, bladder cancer). Invited to participate in the 2024 SRS conference in the United States to share surgical experiences.
Professional Roles
Member of the Robotics Committee of the Shanghai Medical Association; Member of the Nuclear Medicine Committee of the Shanghai Anti-Cancer Association; Deputy Secretary-General of the Medical Robotics Development Promotion Branch of the China Medical Education Association; Secretary-General of the Prostate Cancer Group of the Urology and Male Reproductive System Committee of the Chinese Anti-Cancer Association; Member of the Urology Professional Committee of the China Non-Public Medical Institutions Association; Corresponding Editor of the Chinese Journal of Surgery; Principal author of the "Chinese Anti-Cancer Association Prostate Cancer Guidelines"